Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 33.

Akdis, D; Saguner, A M; Medeiros-Domingo, A; Schaller, A; Balmer, C; Steffel, J; Brunckhorst, C; Duru, F (2018). Multiple clinical profiles of families with the short QT syndrome. Europace, 20(FI1):f113-f121.

Steffel, J; et al; Spahn, D (2016). Expertenbericht zur Anwendung von Edoxaban in der täglichen Praxis. Muttenz: EMH Editions Médicales Suisses SA.

Lüscher, T F; Steffel, J (2015). Individualized antithrombotic therapy. Hämostaseologie, 36(1):26-32.

Steffel, J; Rempel, H; Breitenstein, A; Schmidt, S; Namdar, M; Krasniqi, N; Holzmeister, J; Luscher, T F; Ruschitzka, F; Hurlimann, D (2014). Comprehensive cardiac resynchronization therapy (CRT) optimization in the real world. Cardiology Journal, 21(3):316-324.

Breitenstein, A; Sluka, S H; Akhmedov, A; Stivala, S; Steffel, J; Camici, G G; Riem, H H; Beer, H J; Studt, J D; Duru, F; Luscher, T F; Tanner, F C (2012). Dronedarone reduces arterial thrombus formation. Basic Research in Cardiology, 107(6):302.

Brüllmann, S; Dichtl, W; Paoli, U; Haegeli, L; Schmied, C; Steffel, J; Brunckhorst, C; Hintringer, F; Seifert, Burkhardt; Duru, F; Wolber, T (2012). Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients Aged ≥75 years versus those <75 years. American Journal of Cardiology, 109(5):712-717.

Bonetti, N R; Namdar, M; Günthard, H F; Gruner, C; Greutmann, M; Steffel, J; Hürlimann, D; Ruef, C; Tanner, F C; Jenni, R; Biaggi, P (2012). Early versus late initial echocardiographic assessment in infective endocarditis: similar findings and no difference in clinical outcome. Cardiovascular Medicine, 15(11):317-324.

Steffel, J; Duru, F (2012). Rhythm disorders in isolated left ventricular noncompaction. Annals of Medicine, 44(2):101-108.

Namdar, M; Steffel, J; Jetzer, S; Schmied, C; Hürlimann, D; Camici, G; Bayrak, F; Ricciardi, D; Rao, J Y; de Asmundis, C; Chierchia, G-B; Sarkozy, A; Lüscher, T F; Jenni, R; Duru, F; Brugada, P (2012). Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and fabry disease. American Journal of Cardiology, 109(4):587-593.

Steffel, J; Milosevic, G; Hürlimann, A; Krasniqi, N; Namdar, M; Ruschitzka, F; Lüscher, T F; Duru, F; Holzmeister, J; Hürlimann, D (2011). Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: 'real world' experience from a single tertiary care centre. Heart, 97(20):1668-1674.

Namdar, M; Steffel, J; Vidovic, M; Brunckhorst, C B; Holzmeister, J; Lüscher, T F; Jenni, R; Duru, F (2011). Electrocardiographic changes in early recognition of Fabry disease. Heart, 97(6):485-490.

Steffel, J; Hürlimann, D; Namdar, M; Despotovic, D; Kobza, R; Wolber, T; Holzmeister, J; Haegeli, L; Brunckhorst, C; Lüscher, T F; Jenni, R; Duru, F (2011). Long-term follow-up of patients with isolated left ventricular noncompaction: role of electrocardiography in predicting poor outcome. Circulation Journal, 75(7):1728-34.

Hürlimann, D; Steffel, J; Krasniqi, N; Milosevic, G; Gruner, C; Oswald, F; Rahn, M; Falk, V; Noll, G; Lüscher, T F; Ruschitzka, F; Holzmeister, J (2010). Kardiale Resynchronisationstherapie: "Real World"-Erfahrungen eines tertiären Zentrum in der Schweiz. Cardiovascular Medicine, 13(11):334-341.

Rozenberg, I; Sluka, S H M; Rohrer, L; Hofmann, J; Becher, B; Akhmedov, A; Soliz, J; Mocharla, P; Borén, J; Johansen, P; Steffel, J; Watanabe, T; Lüscher, T F; Tanner, F C (2010). Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(5):923-930.

Wolber, T; On, C J; Brunckhorst, C; Schmied, C; Steffel, J; Lüscher, T F; Duru, F (2010). Patient satisfaction and clinical outcome following outpatient radiofrequency catheter ablation of supraventricular tachycardia. Swiss Medical Weekly, 140(3-4):52-56.

Camici, G G; Steffel, J; Amanovic, I; Breitenstein, A; Baldinger, J; Keller, S; Lüscher, T F; Tanner, F C (2010). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal, 31(2):236-242.

Fröhlich, G; Steffel, J; Hürlimann, D; Enseleit, F; Lüscher, T F; Ruschitzka, F; Abraham, W T; Holzmeister, J (2010). Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. European Heart Journal, 31(12):1477-1485.

Steffel, J; Lüscher, T F (2010). Zelluläre Hämostase - Endothelzellen. In: Pötzsch, B; Madlener, K. Hämostaseologie : Grundlagen, Diagnostik und Therapie. Heidelberg: Springer, 97-104.

Steffel, J; Kobza, R; Oechslin, E; Jenni, R; Duru, F (2009). Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. American Journal of Cardiology, 104(7):984-989.

Steffel, J; Kobza, R; Namdar, M; Wolber, T; Brunckhorst, C; Lüscher, T F; Jenni, R; Duru, F (2009). Electrophysiological findings in patients with isolated left ventricular non-compaction. Europace, 11(9):1193-1200.

Steffel, J; Lüscher, T F (2009). Gerinnungshemmung im akuten Koronarsyndrom. Therapeutische Umschau, 66(4):301-308.

Holzmeister, J; Hürlimann, D; Steffel, J; Ruschitzka, F (2009). Cardiac resynchronization therapy in patients with a narrow QRS. Current Heart Failure Reports, 6(1):49-56.

Steffel, J; Lüscher, T F (2009). Antikoagulation betagter Patienten - Der schmale Grat zwischen Nutzen und Risiko. MMW-Fortschritte der Medizin, 151(16):33-36.

Steffel, J; Hürlimann, D (2009). Current practice of cardiac resynchronization therapy (CRT) in the real world: insights from the European CRT survey. European Heart Journal, 30(20):2433-2435.

Steffel, J; Lüscher, T F (2009). Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. Journal of Cardiovascular Medicine, 10(8):616-623.

Steffel, J; Lüscher, T F (2009). Predicting the development of atherosclerosis. Circulation, 119(7):919-921.

Payeli, S K; Schiene-Fischer, C; Steffel, J; Camic, G G; Rozenberg, I; Lüscher, T F; Tanner, F C (2008). Cyclophilin A differentially activates monocytes and endothelial cells Role of purity, activity, and endotoxin contamination in commercial preparations. Atherosclerosis, 197(2):564-571.

Stähli, B E; Breitenstein, A; Akhmedov, A; Camici, G G; Shojaati, K; Bogdanov, N; Steffel, J; Ringli, D; Lüscher, T F; Tanner, F C (2007). Cardiac glycosides regulate endothelial tissue factor expression in culture. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(12):2769-2776.

Lüscher, T F; Steffel, J; Eberli, F R; Joner, M; Nakazawa, G; Tanner, F C; Virmani, R (2007). Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation, 115(8):1051-1058.

Steffel, J; Lüscher, T F; Tanner, F C (2006). Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation, 113(5):722-731.

Steffel, J; Luscher, T F; Ruschitzka, F; Tanner, F C (2006). Cyclooxygenase-2 inhibition and coagulation. Journal of Cardiovascular Pharmacology, 47 Sup:S15-20.

Steffel, J; Akhmedov, A; Fahndrich, C; Ruschitzka, F; Luscher, T F; Tanner, F C (2006). Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. Biochemical and Biophysical Research Communications (BBRC), 349(2):597-603.

Steffel, J; Hermann, M; Greutert, H; Gay, S; Lüscher, T F; Ruschitzka, F; Tanner, F C (2005). Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation, 111(13):1685-1689.

This list was generated on Thu Aug 16 03:15:57 2018 CEST.